EX-FILING FEES 4 ex_666704.htm EXHIBIT FILING FEES ex_666704.htm

Exhibit 107.1

Calculation of Filing Fee Tables

 

Form S-3
(Form Type)

 

Avenue Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security

Type

  

Security
Class
Title

  

Fee
Calculation 
Rule(1)

  

Amount
Registered(2)

    

Proposed
Maximum
Offering Price
Per Unit(1)

      

Maximum
Aggregate
Offering Price(1)

  

Fee Rate

  

Amount of
Registration Fee

  

Equity

  

Common Stock, par value $0.0001 per share

    

457(c)

    

1,420,741(3)

    

$

4.78

(2)

  

$

6,791,141.98

    

0.00014760

  

$

1,002.37

  
                                               

Total Offering Amounts

                        

$

6,791,141.98

        

$

1,002.37

  

Total Fee Offsets

                                      

—

  

Net Fee Due

                                    

$

1,002.37

  

 

(1) Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant’s Common Stock quoted on The Nasdaq Capital Market LLC on May 2, 2024.

 

(2) Pursuant to Rule 416(a) under the Securities Act, this registration statement also covers an indeterminate number of additional shares as may be issuable as a result of stock splits, stock dividends or similar transactions.

 

(3) Represents 1,420,741 shares of Common Stock issuable upon the exercise of (i) common stock purchase warrants to purchase one share of Common Stock at an exercise price of $6.20, issued to certain selling stockholders on May 1, 2024, and (ii) common stock purchase warrants to purchase one share of Common Stock at an exercise price of $7.75, issued to the Placement Agent or its designees on May 1, 2024.